-+ 0.00%
-+ 0.00%
-+ 0.00%

On November 2, Changshan Pharmaceutical stated on an interactive platform that the company currently has no patents for albumin-coupled dual-target GLP-1 and albumin-coupled three-target GLP-1.

Zhitongcaijing·11/02/2026 07:25:34
Listen to the news
On November 2, Changshan Pharmaceutical stated on an interactive platform that the company currently has no patents for albumin-coupled dual-target GLP-1 and albumin-coupled three-target GLP-1.